Tetsuya Tachiiri

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Diffusion Weighted Imaging

Metastatic Colorectal Cancer

Contrast Enhanced Ultrasound

Top Venues

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Taiji, Nagaaki Marugami, Aki Marugami, Takahiro Itoh, Sho Shimizu, Ryota Nakano, Yuki Hoda, Hideki Kunichika, Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Satoshi Yamauchi, Toshihiro Tanaka
Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review. Diagnostics (Basel, Switzerland) 14 (3) (2024)
Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, Hideyuki Nishiofuku, Nagaaki Marugami, Yuki Tsuji, Tadashi Namisaki, Hitoshi Yoshiji, Toshihiro Tanaka
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri, Kozo Shimizu, Ryosuke Taiji, Aya Yamada, Ryota Nakano, Mariko Irizato, Satoshi Yamauchi, Aki Marugami, Nagaaki Marugami, Hayato Kishida, Hiroyuki Nakagawa, Megumi Takewa, Ken Kageyama, Akira Yamamoto, Eisuke Ueshima, Keitaro Sofue, Ryuichi Kita, Hiroyuki Kurakami, Toshihiro Tanaka
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers 16 (12) (2024)
Ryosuke Taiji, Nagaaki Marugami, Aki Marugami, Takahiro Itoh, Sho Shimizu, Ryota Nakano, Yuki Hoda, Hideki Kunichika, Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Satoshi Yamauchi, Toshihiro Tanaka
Multimodality Imaging of Primary Hepatic Lymphoma: A Case Report and a Literature Review. Diagnostics (Basel, Switzerland) 14 (3) (2024)
Hideki Kunichika, Kiyoyuki Minamiguchi, Tetsuya Tachiiri, Kozo Shimizu, Ryosuke Taiji, Aya Yamada, Ryota Nakano, Mariko Irizato, Satoshi Yamauchi, Aki Marugami, Nagaaki Marugami, Hayato Kishida, Hiroyuki Nakagawa, Megumi Takewa, Ken Kageyama, Akira Yamamoto, Eisuke Ueshima, Keitaro Sofue, Ryuichi Kita, Hiroyuki Kurakami, Toshihiro Tanaka
Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI. Cancers 16 (12) (2024)
Tetsuya Tachiiri, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Hideki Kunichika, Satoshi Yamauchi, Sho Shimizu, Hideyuki Nishiofuku, Nagaaki Marugami, Yuki Tsuji, Tadashi Namisaki, Hitoshi Yoshiji, Toshihiro Tanaka
Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers 16 (9) (2024)
Kiyoyuki Minamiguchi, Hideyuki Nishiofuku, Natsuhiko Saito, Takeshi Sato, Ryosuke Taiji, Takeshi Matsumoto, Shinsaku Maeda, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika, Takashi Inoue, Nagaaki Marugami, Toshihiro Tanaka
Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 15 (4) (2023)
Kiyoyuki Minamiguchi, Hideyuki Nishiofuku, Natsuhiko Saito, Takeshi Sato, Ryosuke Taiji, Takeshi Matsumoto, Shinsaku Maeda, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika, Takashi Inoue, Nagaaki Marugami, Toshihiro Tanaka
Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 15 (4) (2023)
Kiyoyuki Minamiguchi, Hideyuki Nishiofuku, Natsuhiko Saito, Takeshi Sato, Ryosuke Taiji, Takeshi Matsumoto, Shinsaku Maeda, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika, Takashi Inoue, Nagaaki Marugami, Toshihiro Tanaka
Quantitative Analysis of Signal Heterogeneity in the Hepatobiliary Phase of Pretreatment Gadoxetic Acid-Enhanced MRI as a Prognostic Imaging Biomarker in Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. Cancers 15 (4) (2023)